← Leaderboards
Kiana Aran
Keck Graduate Inst Of Applied Life Scis
$2,446,580
Attributed
$3,224,505
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $431.3K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,224,505 · 2
By mechanism
R01$3,224,505 · 2
Top collaborators
- Irina M Conboy4 shared
Others in their field
Other Emerging Leaders on “Organ”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
OrganCellsCell SeparationPublishingIn VivoSickle Cell AnemiaProductionTissuesCurative TreatmentsBaseAllelesBase EditingBindingCrispr/Cas TechnologyDesignConsumptionAmino Acid SequenceComplexCostCollaborationsAffectBlood TransfusionChromatinClustered Regularly Interspaced Short Palindromic Repeats
Grant awards (8)
CRISPR-based transistors for high throughput multiplexed monitoring of CRISPR-based editing efficiency for Sickle cell disease$431,340
R01 · FY2025 · HL · contact PI
CRISPR-based transistors for high throughput multiplexed monitoring of CRISPR-based editing efficiency for Sickle cell disease$422,713
R01 · FY2024 · HL · contact PI
CRISPR-based transistors for high throughput multiplexed monitoring of CRISPR-based editing efficiency for Sickle cells disease$409,227
R01 · FY2023 · HL · contact PI
CRISPR-based transistors for high throughput multiplexed monitoring of CRISPR-based editing efficiency for Sickle cells disease$405,375
R01 · FY2022 · HL · contact PI
New Generation Blood Exchange Devices for Enhancing Tissue Regeneration and Health$385,400
R01 · FY2021 · HL
New Generation Blood Exchange Devices for Enhancing Tissue Regeneration and Health$385,400
R01 · FY2020 · HL
New Generation Blood Exchange Devices for Enhancing Tissue Regeneration and Health$385,400
R01 · FY2019 · HL
New Generation Blood Exchange Devices for Enhancing Tissue Regeneration and Health$399,650
R01 · FY2018 · HL